阳离子表面活性剂增强可生物降解纳米颗粒疫苗的抗原特异性细胞免疫
研究采用改良纳米沉淀法制备50 nm聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒,比较阳离子表面活性剂DOTAP对适应性免疫应答的影响。以卵清蛋白和伯克霍尔德菌外膜蛋白为抗原,发现DOTAP稳定且PLA:PGA为50:50的纳米颗粒显著增强抗原特异性CD8+ T细胞、CD4+ Th1应答和血清IgG滴度,而无表面活性剂的纳米颗粒未能诱导T细胞应答。
要点
- 50 nm PLGA纳米颗粒经DOTAP稳定后可增强CD8+ T细胞和Th1应答。
- 无表面活性剂的纳米颗粒未能诱导T细胞应答且抗体增强效果较弱。
- 该平台以BpOmpW为抗原,展示抗耐药病原体疫苗潜力。
核心结论
- 阳离子表面活性剂DOTAP对PLGA纳米颗粒诱导抗原特异性T细胞和抗体应答至关重要。
研究设计与样本
- 采用改良纳米沉淀法制备50 nm PLGA纳米颗粒,并使用卵清蛋白和伯克霍尔德菌外膜蛋白作为抗原进行验证。
主要发现
- DOTAP稳定且PLA:PGA为50:50的纳米颗粒有效增强抗原特异性CD8+ T细胞、CD4+ Th1应答和血清IgG滴度。
- 无表面活性剂的纳米颗粒未能诱导T细胞应答,且增强抗原特异性抗体的效果较弱。
关键数值与推荐
- 50-60 nm粒径有利于诱导CD8+ T细胞和Th1偏向应答。
- DOTAP稳定且PLA:PGA为50:50的纳米颗粒增强抗原特异性CD8+ T细胞、CD4+ Th1应答和血清IgG滴度。
临床怎么用
- 为开发针对耐药病原体的下一代疫苗提供可生物降解聚合物纳米颗粒平台的设计依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infectious diseases remain a leading cause of morbidity and mortality worldwide and while antimicrobials play a crucial role in controlling infections, the rise of antimicrobial resistance (AMR) is a major global threat. Vaccination is key to prevent and treat diseases caused by resistant pathogens and there is a particular need for vaccines that induce strong T cell-mediated immunity. Nanoparticles comprised of biodegradable polymers, such as poly (lactic-co-glycolic acid) (PLGA), have shown promise due to their biocompatibility, controlled degradation, and capacity for surface modification. A particle size in the 50-60 nm range is beneficial to induce CD8+ T cell and Th1-biased responses. However, manufacturing such small PLGA nanoparticles with traditional approaches such as emulsification/solvent evaporation is challenging. Here, we addressed this challenge and formulated 50 nm polymeric nanoparticles using a modified nanoprecipitation method. We investigated the effect of a cationic surfactant in shaping adaptive immune responses. Nanoparticles stabilized using DOTAP and with a (50:50) PLA:PGA ratio were particularly effective in enhancing antigen-specific CD8+ T cells, CD4+ Th1 responses, and antigen-specific serum IgG titres. Notably, surfactant-free nanoparticles failed to elicit T cell responses and were less effective at enhancing antigen-specific antibodies, highlighting the crucial role of the cationic surfactant in promoting vaccine-induced adaptive immune responses. These findings were validated using ovalbumin (OVA) and Burkholderia pseudomallei outer membrane protein (BpOmpW) as antigens. Given that B. pseudomallei shows both intrinsic and acquired antibiotic resistance, this work underscores the potential of biodegradable polymeric nanoparticles as a promising platform for next-generation vaccines against AMR pathogens.
引用
- Huete-Carrasco J, Aboagye J, Neple D, et al. Cationic surfactant-dependent enhancement of antigen-specific cellular immunity by a biodegradable nanoparticle vaccine. Vaccine. 2026. PMID: 42801865. doi:10.1016/j.vaccine.2026.129195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。